Am J Perinatol 2022; 39(11): 1196-1203
DOI: 10.1055/s-0040-1721716
Original Article

Timing of Delivery in Women with Cardiac Disease

Caroline E. Rouse
1   Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Boston, Harvard Medical School, Boston, Massachusetts
,
Sarah Rae Easter
1   Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Boston, Harvard Medical School, Boston, Massachusetts
,
Valeria E. Duarte
2   Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts
3   Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Sheila Drakely
2   Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts
3   Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Fred M. Wu
2   Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts
3   Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Anne Marie Valente
2   Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts
3   Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Katherine E. Economy
1   Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Boston, Harvard Medical School, Boston, Massachusetts
› Author Affiliations
Funding This study was funded by the Brigham and Women's Hospital Watkins Discovery Award and The Weinberg and Barton Family Fund.

Abstract

Objective Guidelines do not exist to determine timing of delivery for women with cardiovascular disease (CVD) in pregnancy. The neonatal benefit of a term delivery as compared with an early term delivery is well described. We sought to examine maternal outcomes in women with CVD who delivered in the early term period (370/7 through 386/7 weeks) compared with those who delivered later.

Study Design This is a prospective cohort study examining cardiac and obstetric outcomes in women with CVD delivering between September 2011 and December 2016. The associations between gestational age at delivery and maternal, fetal, and obstetric characteristics were evaluated.

Results Two-hundred twenty-five women with CVD were included, 83 (37%) delivered in the early term period and 142 (63%) delivered at term. While the early term group had significantly higher rates of any hypertension during pregnancy (18.1 vs. 7%, p = 0.01) and intrauterine growth restriction (22.9 vs. 2.8%, p < 0.001), there was no difference in high-risk cardiac or obstetric characteristics. No difference in composite cardiac morbidity was found (4.8 vs. 3.5%, p = 0.24). Women in the early term group were more likely to undergo cesarean delivery than women in the term group (43.4 vs. 24.7%, p = 0.004).

Conclusion There is no maternal benefit of an early term delivery in otherwise healthy women with CVD. Given the known fetal consequences of early term delivery, this study offers support to existing literature suggesting term delivery in these women.

Key Points

  • Question of delivery timing in women with cardiac disease.

  • No difference in cardiac morbidity, term versus early term.

  • Term delivery in women with asymptomatic cardiac disease.

Note

This study was presented at Society for Maternal Fetal Medicine's 38th Annual Pregnancy Meeting, Dallas, TX, January 29–February 3, 2018.




Publication History

Received: 18 May 2020

Accepted: 04 November 2020

Article published online:
22 December 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA